TCM Composition for Myocardial Infarction Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for angina pectoris and acute myocardial infarction often rely on drugs with strong toxicity and side effects, and they primarily focus on symptomatic relief rather than addressing the disease progression, with limitations such as nitroglycerin-induced hypotension and tolerance.
Innovation Solution
A traditional Chinese medicine composition comprising 30%∼80% phenolic acid derivatives, 2%~10% tanshinones, and 15%∼60% saponines, specifically formulated to treat acute myocardial infarction and ischemia, utilizing a combination of Danshensu, tanshinones, and saponines to provide anti-inflammatory, anti-coagulant, and cardiovascular benefits.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional drugs (nitrate, nitrite, β-receptor blocker, calcium antagonist) are used to treat angina pectoris, then symptomatic relief is achieved, but toxicity and side effects increase
Solution Approach 1:
The patent uses a composite formulation containing multiple traditional Chinese medicine components (phenolic acid derivatives, tanshinones, saponines, and polysaccharides) working synergistically to treat angina pectoris, replacing single-ingredient conventional drugs with a multi-component composite that achieves therapeutic effects while reducing toxicity and side effects
2Reliability
If nitroglycerin is administered to relieve angina symptoms, then chest pain is reduced, but hypotension and tolerance occur
Solution Approach 1:
The patent employs traditional Chinese medicine compounds as intermediary substances that mediate the therapeutic effect through multiple pathways (anti-inflammatory, antioxidant, vasodilation, platelet inhibition) rather than direct nitric oxide donation, thereby avoiding the harmful effects of nitroglycerin while achieving comparable or superior clinical outcomes
3Ease of operation
If conventional treatments focus on symptomatic relief, then immediate comfort is provided, but disease progression is not addressed
Solution Approach 1:
The patent formulates a multi-functional medication that simultaneously provides symptomatic relief (vasodilation, pain relief) and addresses disease progression (anti-inflammatory, antioxidant, anti-proliferative effects on vascular smooth muscle cells), making a single agent that performs multiple therapeutic roles that were previously required from different medications
Data Source
Figure 1A
Figure 1B
Figure 2A
AI summary
A traditional Chinese medicine composition and preparation thereof for treating cardiovascular diseases is provided. The traditional Chinese medicine composition consists of: by weight percentage, phenolic aicd derivatives 30%∼80%, tanshinones 2%~10% and saponins 15%∼60%.